Bio Protocol借助V2发行平台、流动性引擎和BioAgents演进为DeSci金融层，但收入验证仍处早期。
Investment View
投资者应少看新增发行数量，更关注TVL、持续手续费以及科学IP成果的链上验证。
Source PDF
The PDF report is available alongside the slide viewer.
Report Type
Project Maturity Analysis
Version
v1
Analysis Date
2026年6月25日
Language
zh
Disclaimer: This report is generated through AI-powered analysis and market data. This is not investment advice. All investment decisions should be made at your own risk.